BARDA Releases Five-Year Plan to Combat CBRN Threats
Add bookmark
The U.S. Biomedical Advanced Research Development Authority (BARDA) has released a five-year strategic plan that, among other forecasts, anticipates there will be a number of new projects to combat biological and chemical threats ready for regulatory review in the next few years.
BARDA has presently a robust development pipeline of more than 70 medical countermeasures for chemical, biological, radiological and nuclear threats, according to Robin Robinson, PhD, Director for the Biomedical Adv...
